SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-20-160242
Filing Date
2020-06-04
Accepted
2020-06-04 09:32:25
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d941328d424b5.htm 424B5 508102
2 GRAPHIC g941328g0604000733459.jpg GRAPHIC 3215
3 GRAPHIC g941328g0604000733740.jpg GRAPHIC 3420
4 GRAPHIC g941328g0604000733957.jpg GRAPHIC 5184
  Complete submission text file 0001193125-20-160242.txt   525983
Mailing Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2
Business Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-232569 | Film No.: 20942047
SIC: 2834 Pharmaceutical Preparations